We believe that we are now at a stage where we can also start to combine drug plate screening with SoC therapies such as IR (untreated plateversus 2Gy treated plate) to mimic how these tumours are treated in the clinic and within clinical trials (certainly if TMZ can be removed from the treatment strategy for identified MGMT unmethylated tumours; see above). Here, MGMT is linked to neoplasm.